Majdi M. Sabahelzain

Dr. Majdi M. Sabahelzain

Ahfad University for Women, Omdurman, Khartoum, Sudan
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Current Opinion in Immunology
Verified
Journal Article
Closed access
MSMajdi M. Sabahelzain
Majdi M. Sabahelzain
KHKenneth Hartigan-Go
Kenneth Hartigan-Go
HLHeidi Larson
Heidi Larson

1 February 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
ABAhmed Said Bile
Ahmed Said Bile
MAMohamed Abdullahi Ali-Salad
Mohamed Abdullahi Ali-Salad
AMAmina J. Mahmoud
Amina J. Mahmoud
NSNeha Singh
Neha Singh
NANada Abdelmagid
Nada Abdelmagid
BNBarni Nor
Barni Nor
Somalia is one of 20 countries in the world with the highest numbers of zero-dose children. This study aims to identify who and where zero-dose and under-vaccinated children are and what the existing vaccine delivery strategies to reach zero-dose children in Somalia are. This qualitative study was conducted in three geographically diverse regions of Somalia (rural/remote, nomadic/pastoralists, IDPs, and urban poor population), with government officials and NGO staff (n = 17), and with vaccinators and community members (n = 52). The data were analyzed using the GAVI Vaccine Alliance IRMMA framework. Nomadic populations, internally displaced persons, and populations living in remote and Al-shabaab-controlled areas are three vulnerable and neglected populations with a high proportion of zero-dose children. Despite the contextual heterogeneity of these population groups, the lack of targeted, population-specific strategies and meaningful engagement of local communities in the planning and implementation of immunization services is problematic in effectively reaching zero-dose children. This is, to our knowledge, the first study that examines vaccination strategies for zero-dose and under-vaccinated populations in the fragile context of Somalia. Evidence on populations at risk of vaccine-preventable diseases and barriers to vital vaccination services remain critical and urgent, especially in a country like Somalia with complex health system challenges.

20 June 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMajdi M. Sabahelzain
Majdi M. Sabahelzain
MMMohamed Moukhyer
Mohamed Moukhyer
EDEve Dubé
Eve Dubé
AHAhmed Hardan
Ahmed Hardan
BBBart van Den Borne
Bart van Den Borne
HBHans Bosma
Hans Bosma
Vaccine hesitancy is one of the contributors to low vaccination coverage in both developed and developing countries. Sudan is one of the countries that suffers from low measles vaccine coverage and from measles outbreaks. In order to facilitate the future development of interventions, this study aimed at exploring the opinions of Expanded Program on Immunization officers at ministries of health, WHO, UNICEF and vaccine care providers at Khartoum-based primary healthcare centers. Qualitative data were collected using semi-structured interviews during the period January-March 2018. Data (i.e. quotes) were matched to the categories and the sub-categories of a framework that was developed by the WHO-SAGE Working Group called ''Determinants of Vaccine Hesitancy Matrix''. The interviews were conducted with 14 participants. The majority of participants confirmed the existence of measles vaccine hesitancy in Khartoum state. They further identified various determinants that were grouped into three domains including contextual, groups and vaccination influences. The main contextual determinant as reported is the presence of people who can be qualified as "anti-vaccination". They mostly belong to particular religious and ethnic groups. Parents' beliefs about prevention and treatment from measles are the main determinants of the group influences. Attitude of the vaccine providers, measles vaccine schedule and its mode of delivery were the main vaccine related determinants. Measles vaccine hesitancy in Sudan appears complex and highly specific to local circumstances. To better understand the magnitude and the context-specific causes of measles vaccine hesitancy and to develop adapted strategies to address them, there is clearly a further need to investigate measles vaccine hesitancy among parents.

22 December 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
MSMajdi M. Sabahelzain
Majdi M. Sabahelzain
MMMohamed Moukhyer
Mohamed Moukhyer
Hans BosmaHans Bosma
Hans Bosma
BBBart Van Den Borne
Bart Van Den Borne
Determinants of vaccine hesitancy are not yet well understood. This study aims to assess measles vaccine hesitancy and characterize its determinants among Sudanese parents in Omdurman in Khartoum State. A community-based cross-sectional quantitative study was conducted in Khartoum State in February 2019. The Parent Attitudes about Childhood Vaccination (PACV) was used to measure measles vaccine hesitancy. Questions about the sociodemographic characteristics of the family, the perception of the parents about the measles vaccine, and the parental exposure to information were asked. Proportions of vaccine hesitancy and coefficients of linear regression were computed. Five hundred parents were recruited for the study. We found that a significant proportion of participants (about 1 in 5 parents) had hesitations regarding the measles vaccine. Significant predictors of measles vaccine hesitancy were parental exposure to anti-vaccination information or materials (β = −0.478, p-value < 0.001), the parents’ perception of the effectiveness of measles vaccines (β = 0.093, p-value = 0.020), the age of the mother (β = 0.112, p-value = 0.017), the birth rank of the child (β = −0.116, p-value = 0.015), and the total number of the children in the family (β = 0.098, p-value = 0.013). Vaccination access issues were the common justification for parental vaccination hesitancy. Our findings indicate that investment in vaccine communication as well as addressing access issues might be an effective intervention for improving measles vaccine acceptance and, ultimately, measles vaccine coverage.

30 January 2025 in BMJ Global Health
Verified
Journal Article
Open access
MSMajdi M. Sabahelzain
Majdi M. Sabahelzain
HDHarriet Dwyer
Harriet Dwyer
SASeye Abimbola
Seye Abimbola
JLJulie Leask
Julie Leask
The Sahel region is a geographical belt in Africa that stretches from the Atlantic Ocean to the Red Sea, between the Sahara Desert in the north and the Savannah in the south. It is characterised by challenging environmental crises and conflicts. This analysis highlights the potential implications of conflict on vaccination across five Sahel countries, including Burkina Faso, Chad, Mali, Niger and Sudan, from 2019 to 2023. It also presents recommendations to improve vaccination coverage in these settings. The WHO Immunisation Data Portal was used to extract data about vaccination coverage and disease outbreaks. With the increasing complexity of humanitarian access in the Sahel, there has been an accumulation of the number of zero-dose and underimmunised children. In 2023 alone, most of these countries had a significant proportion of zero-dose children, particularly Sudan (43%), Mali (22%) and Chad (16%). Nearly half of children in Sudan (49%), 33% in Chad and 23% in Mali are underimmunised. Measles vaccine coverage was consistently below 90% in these countries, except for Burkina Faso. The trend of polio outbreaks (circulating vaccine-derived poliovirus) across these countries showed fluctuations in the number of cases, with Niger having reported several cases over this period, and Chad having 101 cases reported in 2020 alone. Despite relatively high coverage, there were significant outbreaks of polio in Burkina Faso, Sudan and Mali in 2020, which reflects the potential impact of the COVID-19 pandemic. Lessons can be learnt from past diplomatic and programmatic successes, while investments in innovative and flexible approaches may help increase the reach of vaccination programmes in inaccessible areas.

28 January 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
MSMajdi M. Sabahelzain
Majdi M. Sabahelzain
MMMohamed Moukhyer
Mohamed Moukhyer
BBBart Van Den Borne
Bart Van Den Borne
Hans BosmaHans Bosma
Hans Bosma
Vaccine uptake is one of the indicators that has been used to guide immunization programs. This study aimed to evaluate whether measles vaccine uptake is predicted by measles vaccine hesitancy. A community-based cross-sectional study was conducted in urban districts in Khartoum state in February 2019. Measles vaccine uptake among children was measured as either fully vaccinated or partially/not vaccinated. The Parent Attitudes about Childhood Vaccines (PACV) scale was used to measure measles vaccine hesitancy. Multivariate logistic regression was run to identify the predictors of measles vaccination uptake, controlling for sociodemographic variables, and the adjusted odds ratios (aORs) with 95% CI were calculated. The receiver operator characteristic (ROC) curve was created, and the area under the curve (AUC) for the PACV was computed. Data were collected from 495 participants. We found that measles vaccine hesitancy (PACV scores) predicts the uptake of measles vaccine after controlling for other potential social confounders, such as the mother’s age and the number of children (aOR 1.055; 95% CI 1.028–1.028). Additionally, the ROC for the PACV yielded an area under the curve (AUC 0.686 (95% CI 0.620–0.751; p < 0.001)). Our findings show that measles vaccine hesitancy in Sudan directly influences the uptake of the measles vaccine. Addressing the determinants of vaccine hesitancy through communication strategies will improve vaccine uptake.